Orakl Oncology raised €11M in a Seed round in Dec 2024. The company is based in Villejuif, France. Investors in the round: Bpifrance, Grand Prix i-Lab, Singular. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €11M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
